Literature DB >> 420832

A 13C NMR method for determination of the transbilayer distribution of phosphatidylcholine in large, unilamellar, protein-free and protein-containing vesicles.

W J Gerritsen, E J van Zoelen, A J Verkleij, B de Kruijff, L L van Deenen.   

Abstract

(1) Large unilamellar vesicles have been prepared from N-[Ne3-13C]-18 : 1c/18 : 1c-phosphatidylcholine, both with and without the major intrinsic proteins from the human erythrocyte membrane incorporated in the bilayer. (2) It is shown that the inside-outside distribution of the lipid molecules in these large unilamellar structures can be determined using 13C NMR. (3) Large vesicles of 18 : 1c/18 : 1c-phosphatidylcholine containing glycophorin show an enhanced permeability to Dy3+. It is shown that the permeability barrier of these vesicles can be restored by addition of 10 mol% 18 : 1c/18 : 1c-phosphatidylethanolamine or 1-18 : 1c-lysophosphatidylcholine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420832     DOI: 10.1016/0005-2736(89)90003-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  NMR studies of the interaction of lipids with glycophorin a in small unilamellar vesicles.

Authors:  J H Prestegard; R Li-da Ong
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

2.  Nuclear magnetic resonance studies of cation transport across vesicle bilayer membranes.

Authors:  D Z Ting; P S Hagan; S I Chan; J D Doll; C S Springer
Journal:  Biophys J       Date:  1981-05       Impact factor: 4.033

3.  Lipid-protein interaction in the glycophorin-dipalmitoylphosphatidylcholine system: Raman spectroscopic investigation.

Authors:  T Taraschi; R Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

4.  31P and 19F NMR studies of glycophorin-reconstituted membranes: preferential interaction of glycophorin with phosphatidylserine.

Authors:  R L Ong
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.